The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

Researchers at Western University and the University of Calgary have discovered how HIV hides in different parts of the body by embedding itself into the DNA of cells in a tissue-specific manner, ...

A second study presented at IDWeek showed that shingles vaccination decreases the risk for death and heart disease — this time among people living with HIV.“Shingles is usually thought of as a painful ...

If someone becomes infected with HIV and does not seek timely treatment, the infection gradually progresses through three stages. Each stage has different symptoms and risks. HIV AIDS: If a person ...

A new drug called lenacapavir might entirely change the game, though.

A man suing as 'John Doe' has filed a complaint at Los Angeles Superior Court alleging that, while interning and seeking a break in the music business in late 2014, he was taken to an after-party in ...

Scientists have used artificial intelligence (AI) to build brand-new viruses, opening the door to AI-designed forms of life. The viruses are different enough from existing strains to potentially ...

Christine Wear’s voice trembles talking about the upcoming flu season. “Anxieties are high,” she said. “We’re trying to navigate what life should look like without being in a bubble.” Wear’s son, ...

According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...

The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...